Published in Cancer Gene Therapy Week, April 17th, 2006
B. Zhang and colleagues, Shandong University, wrote that the study was done "to construct a recombinant adenovirus that can simultaneously express both antisense ODC and AdoMetDC and detect its inhibitory effect on the intracellular polyamine pool and colorectal cancer cell growth.
"A205-bp cDNA of AdoMetDC was reverse-inserted into recombinant pAdTrack-ODCas vectors and recombined with pAdEasy-1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Gene Therapy Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.